The pharmaceutical industry’s argument that capping drug prices would compromise drug innovation stands “on very shaky ground.”
The term “vast” sets a high bar.
Former Vice President Joe Biden’s claim during the latest Democratic presidential debate relies on a squishy number, and the context matters.
Surgeon General Jerome Adams said the drug has a “unique impact” on the developing brain — technically true, but neglecting a vital comparison to other drugs, as well as shortcomings in the existing research.
Big picture remains hazy, but these numbers add up.
Polling supports Buttigieg’s claim.
Warren’s claim on health insurance and bankruptcy is narrow enough to hold up.
It comes down to questionable methodology.
The topic, which polls show is top of mind among voters, kept returning throughout the fourth debate of Democratic presidential candidates.
The president’s outline of key health policy concerns touched on a variety of hot-button issues from drug prices to immigration.